Target intelligence / Profile preview

Novel transcript antisense to solute carrier family 25 member 26 (ENSG00000307959)

Target
ENSG00000307959
Molecular classification
Other
01

Overview

The entity "novel transcript, antisense to SLC25A26" (ENSG00000307959) refers to a predicted or uncharacterized transcript located antisense to the solute carrier family 25 member 26 (SLC25A26) gene region. There is currently no curated information or characterization indicating that this transcript is a recognized therapeutic target, enzyme, transporter, receptor, or protein-coding gene. The canonical human gene in this region, SLC25A26, encodes the mitochondrial S-adenosylmethionine carrier, which is involved in mitochondrial methylation processes and is implicated in cancer and mitochondrial disease[1][2][3]. In contrast, the antisense "novel transcript" is neither established as a molecular target nor well documented. Its nomenclature and lack of functional assignment suggest potential issues with annotation, incomplete information, or that it is simply a computational prediction without biological validation.

Beyond the preview

Go deeper on Novel transcript antisense to solute carrier family 25 member 26 (ENSG00000307959).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript antisense to solute carrier family 25 member 26 (ENSG00000307959).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call